NCT00003509 2020-12-19Antineoplaston Therapy in Treating Patients With Stage IV MelanomaBurzynski Research InstitutePhase 2 Terminated13 enrolled 5 charts
NCT00003514 2013-07-10Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation TherapyNational Cancer Institute (NCI)Phase 2 Withdrawn